SYX-1097

N/A

Report date: 2024/07/16 11:54:57
NME

Base Information

Drug NameSYX-1097
Drug Alias NameSYX-1097
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA polymerase theta inhibitors
TargetsDNA polymerase theta
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSynrx Therapeutics (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSynrx Therapeutics (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A